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The epithelial sodium channel (ENaC) is a mem-
ber of the ENaC/degenerin family of non-voltage
gated ion channels. ENaC is localized in the apical
membrane of epithelial cells, and is the rate limit-
ing step for sodium absorption in a number of epi-
thelial tissues like the aldosterone-sensitive distal
nephron (ASDN), respiratory epithelia, distal colon,
sweat and salivary ducts. ENaC is probably a het-
erotrimer with three well characterized subunits
(αβγ). In humans an additional δ-subunit (δ-hENaC)
exists but little is known about its function.
The regulation of ENaC is highly complex (1)
and proteolytic processing of ENaC is thought to
contribute to its activation under physiological and
pathophysiological conditions (2-4). Proteases con-
tribute to ENaC regulation by cleaving specific sites
in the extracellular loops of the α - and γ -subunits
but not the β -subunit. The channel is thought to
be in its mature and active form in its cleaved
state, but there is evidence for the presence of both
cleaved and non-cleaved channels in the plasma
membrane. Cleavage may activate the channel by
changing its conformation probably by releasing in-
hibitory peptides from the extracellular loops of α -
and γ -ENaC.
Airway-specific over-expression of the β -subunit
of ENaC has recently been shown to cause airway
surface liquid depletion and cystic fibrosis (CF) like
lung disease (5). In the kidney ENaC is critically
important for the maintenance of body sodium bal-
ance (1). This is evidenced by gain of function mu-
tations of ENaC which cause a severe form of arte-
rial hypertension known as Liddle’s syndrome.
Loss-of-function mutations of ENaC cause pseudo-
hypoaldosteronism type I (PHA1), a disease char-
acterized by renal salt wasting. Patients with PHA1
may also suffer from respiratory symptoms similar
to those of patients with atypical CF. In PHA1 a re-
duction of ENaC-mediated Na+ absorption in respi-
ratory epithelia is thought to favor fluid secretion
in the respiratory tract (6).
These examples illustrate the importance of ENaC
function and the need for an appropriate regulation
of ENaC activity in a tissue specific manner. Most
of our knowledge about ENaC activation by extra-
cellular proteases stems from studies in model sys-
tem like Xenopus laevis oocytes (7) and cultured
cells. Recently, functional evidence is emerging that
ENaC activation by extracellular proteases can oc-
cur in native tissue (8). Inappropriate ENaC activa-
tion by endogenous proteases may be involved in
sodium retention in nephrotic syndrome (9) and
may aggravate symptoms of cystic fibrosis during
acute respiratory infections associated with the gen-
eration of local proteases. Moreover, ENaC may be
a modifier gene in patients with cystic fibrosis. In-
deed, ENaC polymorphisms with a gain-of-function
and a loss-of-function effect have been identified
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in patients with atypical CF (10). At present it is
unclear why some loss-of-function mutations of
ENaC mainly manifest as a renal salt wasting syn-
drome (PHA1) while others cause CF-like pulmo-
nary symptoms without overt renal disease. Organ
specific differences in ENaC processing and activa-
tion and differences in the genetic background may
be responsible for the development of different dis-
ease phenotypes.
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